abstract |
The present invention concerns the use of compounds for preventing and/or treating diabetes, for modulating glucose, insulin, and/or triglyceride levels; for reducing blood glucose level; for maintaining or increasing insulin level; for increasing insulin secretion; increasing insulin sensitivity; or decreasing insulin resistance in a subject. These novel uses have been found for compounds represented by Formula I and pharmaceutically acceptable salts. wherein A is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(0)-(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4; R 1 is H, F or OH; R 2 is C 5 alkyl, C 6 alkyl, C 5 alkenyl, C 6 alkenyl, C(0)-(CH 2 ) n —CH 3 or CH(OH)—(CH 2 ) n —CH 3 wherein n is 3 or 4; R 3 is H, F, OH or CH 2 Ph; R 4 is H, F or OH; Q is 1) (CH 2 ) m C(O)OH wherein m is 1 or 2, 2) CH(CH 3 )C(O)OH, 3) C(CH 3 ) 2 C(O)OH, 4) CH(F)—C(O)OH, 5) CF 2 —C(O)OH, or 6) C(O)—C(O)OH. |